Alpha 2.0
Login Register
» Articles » PMID: 1846464

Final Analysis of Primary Cytomegalovirus Disease Prevention in Renal Transplant Recipients with a Cytomegalovirus-immune Globulin: Comparison of the Randomized and Open-label Trials

Overview
Journal Transplant Proc
Specialty General Surgery
Date 1991 Feb 11
PMID 1846464
Citations 7
Authors
D R Snydman
B G Werner
N L Tilney
R L Kirkman
E L Milford
S I Cho
H L Bush Jr
A S Levey
T B Strom
C B Carpenter
Affiliations
Soon will be listed here.
Citing Articles

Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis.

Barten M, Baldanti F, Staus A, Huber C, Glynou K, Zuckermann A Life (Basel). 2022; 12(3).

PMID: 35330112 PMC: 8955988. DOI: 10.3390/life12030361.

A Systematic Review and Meta-analysis of Prophylactic versus Pre-emptive Strategies for Preventing Cytomegalovirus Infection in Renal Transplant Recipients.

Rawal B, Shadrou S, Abubacker F, Ghahramani N Int J Organ Transplant Med. 2014; 3(1):10-7.

PMID: 25013618 PMC: 4089275.

Introduction: disease overview and risk factors.

P T. 2010; 35(3 Section 3):2-4.

PMID: 20442813 PMC: 2851494.

Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.

Hemming V Clin Diagn Lab Immunol. 2001; 8(5):859-63.

PMID: 11527792 PMC: 96160. DOI: 10.1128/CDLI.8.5.859-863.2001.

Criteria for the appropriate drug utilisation of immunoglobulin.

Thurmann P, Harder S Pharmacoeconomics. 1996; 9(5):417-29.

PMID: 10160254 DOI: 10.2165/00019053-199609050-00005.